The Need for Ready-To-Administer Solutions in Acute Care

Information

By switching from vials and ampules to glass prefillable syringes, hospitals have the potential to reduce medical errors, improve workflow efficiency and impact return on investment for hospital stakeholders. This webinar will address how for pharmaceutical companies, transitioning a fixed dose drug from its vial or ampule format to a prefilled syringe can serve as a differentiation strategy in a market dominated by vials and ampules. Also discussed will be how BD uniquely answers connection performance challenges experienced by hospitals when using glass prefillable syringes for IV applications.

Discussion Points

• Market need for converting generic acute drugs from Vial to Ready-Administer solutions

• Evidence on the use of Ready-Administer drugs

• Different Ready-Administer solutions currently available

SAS Becton Dickinson FranceAs a partner of choice for the pharmaceutical and biotech companies across the globe, BD Medical - Pharmaceutical Systems provides a broad range of parenteral drug delivery systems including glass and plastic prefillable syringes, safety and shielding systems as well as advanced drug delivery solutions that help ensure smooth delivery, regardless of drug complexity, viscosity and dosing volume. Our services and solutions help you from development all the way through to launch, while accelerating time to market and helping to reduce risks.

Registered attendees

Akihiro Shimizu

MarketingIwata Label Co., Ltd,

Alfred Leibbrand

Product EngineerBD Medical - Pharmaceutical systems

Audrey Chardonnet

Senior Director, Global Market DevelopmentAptar Pharma

The Need for Ready-To-Administer Solutions in Acute Care

Information

Registered attendees

Log in

Log in